Table 3.
Characteristics of skin cancers and safety margins.
| No | Sex | Age | Diagnosis | Location | Horizontal margin (cm) | Vertical margin | Follow up (month) | Recurrence |
| 1 | F | 81 | Merkel cell carcinoma | Cheek | 2 | Subcutaneous fat layer | 7.2 | – |
| 2 | M | 83 | Basal cell carcinoma | Cheek | 1 | Subcutaneous fat layer | 3.1 | – |
| 3 | M | 86 | Squamous cell carcinoma | Forehead | 1.5 | Subcutaneous fat layer | 15.0 | – |
| 4 | M | 64 | Basal cell carcinoma | Cheek | 1, 0.5 (lid cheek junction) | Subcutaneous fat (positive deep margin in frozen biopsy) −> Superficial muscle (negative deep margin) | 4.6 | – |
| 5 | F | 61 | Basal cell carcinoma | Neck | 1 | Subcutaneous fat layer | 8.9 | – |
| 6 | F | 87 | Basal cell carcinoma | Scalp | 0.5 | Subcutaneous fat layer | 3.1 | – |
| 7 | M | 77 | Basal cell carcinoma | Nose | 0.5 | Subcutaneous fat layer | 5.1 | – |
| 8 | F | 46 | Basal cell carcinoma | Cheek | 0.5 | Subcutaneous fat layer | 24.0 | – |
| 9 | M | 61 | Basal cell carcinoma | Nose | 0.5 | Subcutaneous fat layer | 23.2 | – |
| 10 | M | 66 | Basal cell carcinoma | Nose | 0.4 | Subcutaneous fat layer | 12.6 | |
| 11 | F | 65 | Basal cell carcinoma | Nose | 0.3 | Subcutaneous fat layer | 20.2 | – |
| 12 | M | 58 | Basal cell carcinoma | Temple | 0.5 | Subcutaneous fat layer | 5.7 | – |
| 13 | M | 84 | Basal cell carcinoma | Cheek | 0.3 | Subcutaneous fat layer | 17.5 | – |
| 14 | F | 79 | Basal cell carcinoma | Nose | 0.4 | Subcutaneous fat layer | 11.5 | – |
| 15 | F | 84 | Squamous cell carcinoma | Cheek | 1 | Subcutaneous fat layer | 13.3 | – |
| 16 | M | 83 | Squamous cell carcinoma in situ | Buttock | 1 | Subcutaneous fat layer | 2.5 | – |
| 17 | M | 69 | Basal cell carcinoma | Cheek | 0.5 | Subcutaneous fat layer | 12.3 | – |
| 18 | M | 46 | Squamous cell carcinoma in situ | Sole | 0.5 | Subcutaneous fat layer | 11.9 | – |
| 19 | F | 80 | Squamous cell carcinoma in situ | Nose | 0.5 | Superficial muscle | 8.3 | – |
| 20 | F | 78 | Squamous cell carcinoma | Nose | 0.4 | Subcutaneous fat layer | 8.6 | – |
| 22 | M | 78 | Squamous cell carcinoma | Cheek | 1 | Superficial muscle | 10.6 | – |
| 21 | F | 79 | Basal cell carcinoma | Forehead | 0.5 | Subcutaneous fat layer | 3.6 | – |
| 23 | M | 77 | Basal cell carcinoma | Nose | 0.5 | Subcutaneous fat layer | 10.0 | – |
| 24 | M | 73 | Squamous cell carcinoma in situ | Index finger | 1 | Deep fascia | 5.9 | – |
| 25 | F | 59 | Squamous cell carcinoma in situ | Suprapubic area | 1 | Superficial fascia | 6.9 | – |
| 26 | F | 77 | Squamous cell carcinoma in situ | Lower leg | 1 | Superficial fascia | 5.6 | – |
| 27 | F | 84 | Basal cell carcinoma | Neck | 0.5 | Plastysma | 3.5 | – |
| 28 | M | 67 | Mucinous carcinoma | Cheek | 1 | Superficial musculoaponeurotic system (SMAS) | 3.1 | – |
| 29 | M | 55 | Basal cell carcinoma | Mastoid area | 1 | Subcutaneous fat layer | 2.6 | – |
| 30 | F | 87 | Sebaceous carcinoma | Upper eyelid | 0.5 | Full thickness eyelid | 2.0 | – |